Neuroadaptation of GABAergic transmission in the central amygdala during chronic morphine treatment

Addiction Biology

Volumn 16, Issue 4, 2011, Pages 551-564

  Bajo, Michal ^a   Roberto, Marisa ^a   Madamba, Samuel G ^a   Siggins, George Robert ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Addiction; drug abuse; electrophysiology; extended amygdala; opiate; tolerance

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MORPHINE; MU OPIATE RECEPTOR;

4 AMINOBUTYRIC ACID RELEASE; ADAPTATION; AMPLITUDE MODULATION; AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CONTROLLED STUDY; DRUG TOLERANCE; ELECTRIC CURRENT; FACILITATION; GABAERGIC TRANSMISSION; INHIBITORY POSTSYNAPTIC CURRENT; INHIBITORY POSTSYNAPTIC POTENTIAL; LONG TERM CARE; MALE; MINIATURE ENDPLATE POTENTIAL; NERVE CELL MEMBRANE POTENTIAL; NEUROADAPTATION; NEUROMODULATION; NONHUMAN; PAIRED PULSE FACILITATION; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT;

AMYGDALA; ANALGESICS, OPIOID; ANIMALS; DRUG TOLERANCE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; INHIBITORY POSTSYNAPTIC POTENTIALS; MALE; MINIATURE POSTSYNAPTIC POTENTIALS; MORPHINE; NARCOTICS; NEURONS; PATCH-CLAMP TECHNIQUES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GABA-A; RECEPTORS, OPIOID, MU; SOMATOSTATIN; SYNAPTIC TRANSMISSION;

EID: 80052985490     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2010.00269.x     Document Type: Article

References (56)

1. Aggleton JP, (1993) The contribution of the amygdala to normal and abnormal emotional states. Trends Neurosci 16: 328-333. (Pubitemid 23190650)
2. Cahill L, McGaugh JL, (1998) Mechanisms of emotional arousal and lasting declarative memory. Trends Neurosci 21: 294-299. (Pubitemid 28293639)
3. Carr KD, Kutchukhidze N, Park TH, (1999) Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala. Brain Res 822: 34-42. (Pubitemid 29222827)
4. Cassell MD, Freedman LJ, Shi C, (1999) The intrinsic organization of the central extended amygdala. Ann NY Acad Sci 877: 217-241. (Pubitemid 29351860)
5. Cassell MD, Gray TS, Kiss JZ, (1986) Neuronal architecture in the rat central nucleus of the amygdala: a cytological, hodological, and immunocytochemical study. J Comp Neurol 246: 478-499. (Pubitemid 16079511)
6. Chieng B, Christie MJ, (1995) Lesions to terminals of noradrenergic locus coeruleus neurones do not inhibit opiate withdrawal behaviour in rats. Neurosci Lett 186: 37-40.
7. Chieng BC, Christie MJ, Osborne PB, (2006) Characterization of neurons in the rat central nucleus of the amygdala: cellular physiology, morphology, and opioid sensitivity. J Comp Neurol 497: 910-927. (Pubitemid 44051509)
8. Christie MJ, (2008) Cellular neuroadaptations to chronic opioids: tolerance, withdrawal and addiction. Br J Pharmacol 154: 384-396. (Pubitemid 351670590)
9. Davis M, Shi C, (2000) The amygdala. Curr Biol 10: R131.
10. Dunbar SA, Karamian I, Yeatman A, Zhang J, (2006) Effects of recurrent withdrawal on spinal GABA release during chronic morphine infusion in the rat. Eur J Pharmacol 535: 152-156.
11. Everitt BJ, Cardinal RN, Parkinson JA, Robbins TW, (2003) Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann NY Acad Sci 985: 233-250. (Pubitemid 36521118)
12. Fallon JH, Leslie FM, (1986) Distribution of dynorphin and enkephalin peptides in the rat brain. J Comp Neurol 249: 293-336. (Pubitemid 16059334)
13. Finnegan TF, Chen SR, Pan HL, (2005) Effect of the {mu} opioid on excitatory and inhibitory synaptic inputs to periaqueductal gray-projecting neurons in the amygdala. J Pharmacol Exp Ther 312: 441-448. (Pubitemid 40189540)
14. Fox RJ, Sorenson CA, (1994) Bilateral lesions of the amygdala attenuate analgesia induced by diverse environmental challenges. Brain Res 648: 215-221. (Pubitemid 24186919)
15. Gallagher M, Chiba AA, (1996) The amygdala and emotion. Curr Opin Neurobiol 6: 221-227. (Pubitemid 26168481)
16. Georges F, Stinus L, Le Moine C, (2000) Mapping of c-fos gene expression in the brain during morphine dependence and precipitated withdrawal, and phenotypic identification of the striatal neurons involved. Eur J Neurosci 12: 4475-4486. (Pubitemid 32040927)
17. Gestreau C, Le Guen S, Besson JM, (2000) Is there tonic activity in the endogenous opioid systems? A c-Fos study in the rat central nervous system after intravenous injection of naloxone or naloxone-methiodide. J Comp Neurol 427: 285-301.
18. Gold LH, Stinus L, Inturrisi CE, Koob GF, (1994) Prolonged tolerance, dependence and abstinence following subcutaneous morphine pellet implantation in the rat. Eur J Pharmacol 253: 45-51. (Pubitemid 24063426)
19. Gray TS, Cassell MD, Kiss JZ, (1984) Distribution of pro- opiomelanocortin-derived peptides and enkephalins in the rat central nucleus of the amygdala. Brain Res 306: 354-358. (Pubitemid 14090475)
20. Hack SP, Vaughan CW, Christie MJ, (2003) Modulation of GABA release during morphine withdrawal in midbrain neurons in vitro. Neuropharmacology 45: 575-584. (Pubitemid 36980814)
21. Hashimoto K, Amano T, Sakai N, Suzuki T, Narita M, (2009) Cell-dependent physiological synaptic action of morphine in the rat habenular nucleus: morphine both inhibits and facilitates excitatory synaptic transmission. Neurosci Lett 451: 270-273.
22. Helmstetter FJ, (1992) Contribution of the amygdala to learning and performance of conditional fear. Physiol Behav 51: 1271-1276.
23. Ingram SL, Vaughan CW, Bagley EE, Connor M, Christie MJ, (1998) Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci 18: 10269-10276. (Pubitemid 29016546)
24. Jolas T, Nestler EJ, Aghajanian GK, (2000) Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an up-regulation of the cyclic AMP pathway. Neuroscience 95: 433-443.
25. Kang-Park MH, Kieffer BL, Roberts AJ, Roberto M, Madamba SG, Siggins GR, Moore SD, (2009) Mu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: lack of ethanol interactions. J Pharmacol Exp Ther 328: 284-293.
26. Kieffer BL, (2000) Opioid receptors: from genes to mice. J Pain 1: 45-50.
27. Kirschke C, Schadrack J, Zieglgänsberger W, Spanagel R, (2002) Effects of morphine withdrawal on micro-opioid receptor-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate autoradiography in rat brain. Eur J Pharmacol 446: 43-51. (Pubitemid 34722556)
28. Koob GF, (1999) The role of the striatopallidal and extended amygdala systems in drug addiction. Ann NY Acad Sci 877: 445-460. (Pubitemid 29351872)
29. Koob GF, Bloom FE, (1988) Cellular and molecular mechanisms of drug dependence. Science 242: 715-723.
30. Koob GF, Le Moal M, (2005) Plasticity of reward neurocircuitry and the 'dark side' of drug addiction. Nat Neurosci 8: 1442-1444. (Pubitemid 41573653)
31. Koob GF, Sanna PP, Bloom FE, (1998) Neuroscience of addiction. Neuron 21: 467-476. (Pubitemid 28475499)
32. Lam MP, Marinelli PW, Bai L, Gianoulakis C, (2008) Effects of acute ethanol on opioid peptide release in the central amygdala: an in vivo microdialysis study. Psychopharmacology (Berl) 201: 261-271.
33. LeDoux J, (2003) The emotional brain, fear, and the amygdala. Cell Mol Neurobiol 23: 727-738.
34. LeDoux J, (2007) The amygdala. Curr Biol 17: R868-R874.
35. Maher CE, Eisenach JC, Pan HL, Xiao R, Childers SR, (2001) Chronic intrathecal morphine administration produces homologous mu receptor/G-protein desensitization specifically in spinal cord. Brain Res 895: 1-8. (Pubitemid 32231131)
36. Mansour A, Fox CA, Burke S, Meng F, Thompson RC, Akil H, Watson SJ, (1994) Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J Comp Neurol 350: 412-438. (Pubitemid 24356007)
37. Neal CR, Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Akil H, Watson SJ, Jr, (1999a) Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: comparison of ORL1 receptor mRNA expression with (125)I-[(14)Tyr]-orphanin FQ binding. J Comp Neurol 412: 563-605. (Pubitemid 29409672)
38. Neal CR, Jr, Mansour A, Reinscheid R, Nothacker HP, Civelli O, Watson SJ, Jr, (1999b) Localization of orphanin FQ (nociceptin) peptide and messenger RNA in the central nervous system of the rat. J Comp Neurol 406: 503-547. (Pubitemid 29144937)
39. Pierce TL, Wessendorf MW, (2000) Immunocytochemical mapping of endomorphin-2-immunoreactivity in rat brain. J Chem Neuroanat 18: 181-207. (Pubitemid 30227332)
40. Pitkanen A, Savander V, LeDoux JE, (1997) Organization of intra-amygdaloid circuitries in the rat: an emerging framework for understanding functions of the amygdala. Trends Neurosci 20: 517-523. (Pubitemid 27459657)
41. Roberto M, Madamba SG, Stouffer DG, Parsons LH, Siggins GR, (2004) Increased GABA release in the central amygdala of ethanol-dependent rats. J Neurosci 24: 10159-10166. (Pubitemid 39492041)
42. Sah P, Faber ES, Lopez De Armentia M, Power J, (2003) The amygdaloid complex: anatomy and physiology. Physiol Rev 83: 803-834. (Pubitemid 36828926)
43. See RE, Fuchs RA, Ledford CC, McLaughlin J, (2003) Drug addiction, relapse, and the amygdala. Ann NY Acad Sci 985: 294-307. (Pubitemid 36521122)
44. Sim LJ, Selley DE, Dworkin SI, Childers SR, (1996) Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J Neurosci 16: 2684-2692.
45. Singh ME, Verty AN, Price I, McGregor IS, Mallet PE, (2004) Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716. Neuropharmacology 47: 1157-1169. (Pubitemid 39572707)
46. Stornetta RL, Norton FE, Guyenet PG, (1993) Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res 624: 19-28. (Pubitemid 23281797)
47. Swanson LW, Petrovich GD, (1998) What is the amygdala? Trends Neurosci 21: 323-331. (Pubitemid 28341956)
48. Tao R, Auerbach SB, (1994) Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine. J Neurochem 63: 517-524. (Pubitemid 24233684)
49. Tao R, Auerbach SB, (2000) Regulation of serotonin release by GABA and excitatory amino acids. J Psychopharmacol 14: 100-113. (Pubitemid 30389485)
50. Tao R, Ma Z, Auerbach SB, (2000) Differential effect of local infusion of serotonin reuptake inhibitors in the raphe versus forebrain and the role of depolarization-induced release in increased extracellular serotonin. J Pharmacol Exp Ther 294: 571-579. (Pubitemid 30490831)
51. Van der Kloot W, (1991) The regulation of quantal size. Prog Neurobiol 36: 93-130.
52. Veinante P, Stoeckel ME, Lasbennes F, Freund-Mercier MJ, (2003) c-Fos and peptide immunoreactivities in the central extended amygdala of morphine-dependent rats after naloxone-precipitated withdrawal. Eur J Neurosci 18: 1295-1305. (Pubitemid 37115048)
53. Williams JT, Christie MJ, Manzoni O, (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81: 299-343. (Pubitemid 32096178)
54. Wilson MA, Mascagni F, McDonald AJ, (2002) Sex differences in delta opioid receptor immunoreactivity in rat medial amygdala. Neurosci Lett 328: 160-164. (Pubitemid 34804734)
55. Zhu W, Pan ZZ, (2004) Synaptic properties and postsynaptic opioid effects in rat central amygdala neurons. Neuroscience 127: 871-879. (Pubitemid 39099552)
56. Zhu W, Pan ZZ, (2005) Mu-opioid-mediated inhibition of glutamate synaptic transmission in rat central amygdala neurons. Neuroscience 133: 97-103. (Pubitemid 40694161)